M. Ellen Kuenzig
M. Ellen Kuenzig
SickKids Hospital
Verified email at sickkids.ca
Title
Cited by
Cited by
Year
Comparative effectiveness of immunosuppressants and biologics for inducing and maintaining remission in Crohn's disease: a network meta-analysis
GS Hazlewood, A Rezaie, M Borman, R Panaccione, S Ghosh, CH Seow, ...
Gastroenterology 148 (2), 344-354. e5, 2015
2452015
Past and future burden of inflammatory bowel diseases based on modeling of population-based data
S Coward, F Clement, EI Benchimol, CN Bernstein, JA Avina-Zubieta, ...
Gastroenterology 156 (5), 1345-1353. e4, 2019
1312019
Budesonide for induction of remission in Crohn's disease
A Rezaie, ME Kuenzig, EI Benchimol, AM Griffiths, AR Otley, AH Steinhart, ...
Cochrane Database of Systematic Reviews, 2015
1072015
Budesonide for maintenance of remission in Crohn's disease
ME Kuenzig, A Rezaie, CH Seow, AR Otley, AH Steinhart, AM Griffiths, ...
Cochrane Database of Systematic Reviews, 2014
912014
Rural and urban residence during early life is associated with risk of inflammatory bowel disease: a population-based inception and birth cohort study
EI Benchimol, GG Kaplan, AR Otley, GC Nguyen, FE Underwood, ...
The American journal of gastroenterology 112 (9), 1412, 2017
802017
Comparative effectiveness of mesalamine, sulfasalazine, corticosteroids, and budesonide for the induction of remission in Crohn's disease: a Bayesian network meta-analysis
S Coward, ME Kuenzig, G Hazlewood, F Clement, K McBrien, R Holmes, ...
Inflammatory bowel diseases 23 (3), 461-472, 2017
492017
Smoking influences the need for surgery in patients with the inflammatory bowel diseases: a systematic review and meta-analysis incorporating disease duration
ME Kuenzig, SM Lee, B Eksteen, CH Seow, C Barnabe, R Panaccione, ...
BMC gastroenterology 16 (1), 1-9, 2016
452016
The impact of inflammatory bowel disease in Canada 2018: direct costs and health services utilization
ME Kuenzig, EI Benchimol, L Lee, LE Targownik, H Singh, GG Kaplan, ...
Journal of the Canadian Association of Gastroenterology 2 (Supplement_1 …, 2019
442019
The impact of inflammatory bowel disease in Canada 2018: children and adolescents with IBD
MW Carroll, ME Kuenzig, DR Mack, AR Otley, AM Griffiths, GG Kaplan, ...
Journal of the Canadian Association of Gastroenterology 2 (Supplement_1 …, 2019
412019
Co-occurrence of asthma and the inflammatory bowel diseases: a systematic review and meta-analysis
ME Kuenzig, K Bishay, R Leigh, GG Kaplan, EI Benchimol, CSRR Team
Clinical and translational gastroenterology 9 (9), 2018
322018
Asthma is associated with subsequent development of inflammatory bowel disease: a population-based case–control study
ME Kuenzig, C Barnabe, CH Seow, B Eksteen, ME Negron, A Rezaie, ...
Clinical Gastroenterology and Hepatology 15 (9), 1405-1412. e3, 2017
312017
The impact of inflammatory bowel disease in Canada 2018: A scientific report from the Canadian gastro-intestinal epidemiology consortium to Crohn’s and colitis Canada
EI Benchimol, CN Bernstein, A Bitton, SK Murthy, GC Nguyen, K Lee, ...
Journal of the Canadian Association of Gastroenterology 2 (Supplement_1), S1-S5, 2019
272019
Rural and urban disparities in the care of Canadian patients with inflammatory bowel disease: a population-based study
EI Benchimol, ME Kuenzig, CN Bernstein, GC Nguyen, A Guttmann, ...
Clinical epidemiology 10, 1613, 2018
262018
Long-term outcomes of pediatric inflammatory bowel disease
S Nasiri, ME Kuenzig, EI Benchimol
Seminars in pediatric surgery 26 (6), 398-404, 2017
262017
The impact of inflammatory bowel disease in Canada 2018: indirect costs of IBD care
ME Kuenzig, L Lee, W El-Matary, AV Weizman, EI Benchimol, GG Kaplan, ...
Journal of the Canadian Association of Gastroenterology 2 (Supplement_1 …, 2019
252019
Longitudinal trends in the direct costs and health care utilization ascribable to inflammatory bowel disease in the biologic era: Results from a Canadian population–based analysis
LE Targownik, GG Kaplan, J Witt, CN Bernstein, H Singh, A Tennakoon, ...
Official journal of the American College of Gastroenterology| ACG 115 (1 …, 2020
222020
Combined biologic and immunomodulatory therapy is superior to monotherapy for decreasing the risk of inflammatory bowel disease-related complications
LE Targownik, EI Benchimol, CN Bernstein, H Singh, A Tennakoon, ...
Journal of Crohn's and Colitis 14 (10), 1354-1363, 2020
202020
Fecal incontinence in inflammatory bowel disease: a systematic review and meta-analysis
P Gu, ME Kuenzig, GG Kaplan, M Pimentel, A Rezaie
Inflammatory bowel diseases 24 (6), 1280-1290, 2018
202018
The effect of initiation of anti-TNF therapy on the subsequent direct health care costs of inflammatory bowel disease
LE Targownik, EI Benchimol, J Witt, CN Bernstein, H Singh, L Lix, ...
Inflammatory bowel diseases 25 (10), 1718-1728, 2019
192019
Risk of venous thromboembolism after hospital discharge in patients with inflammatory bowel disease: a population-based study
JD McCurdy, ME Kuenzig, G Smith, S Spruin, SK Murthy, M Carrier, ...
Inflammatory bowel diseases 26 (11), 1761-1768, 2020
172020
The system can't perform the operation now. Try again later.
Articles 1–20